MedicaidCoverageHigh impact
MAB2020050103
Pennsylvania Medicaid (DHS)·PA·Provider Bulletin
Effective date
Mar 1, 2020
We identified it
Jun 20, 2026
Summary
Pennsylvania Medicaid has suspended all copayment requirements for COVID-19 testing, testing-related services, and treatment effective March 1, 2020. Providers must include appropriate COVID-19 diagnosis codes on claims and cannot collect copayments for these services.
Action Required
Immediately: Billing team must stop collecting copayments for all COVID-19 testing and treatment services for PA Medicaid patients with dates of service March 1, 2020 and after. Ensure all COVID-19 related claims include appropriate COVID-19 diagnosis codes as specified in provider Quick Tips from March 17 and March 27, 2020. Update billing system to automatically waive copayments for covered COVID-19 services and medications including acetaminophen, antidiarrheals, antiemetics, antihistamines, anti-infectives, asthma/COPD medications, and ophthalmic products.